Yingtong Lin

机构：Sun Yat-sen University, Sichuan University, Guangzhou University, West China Hospital of Sichuan University, Taipei Medical University · ORCID：0000-0003-4665-7107

发表论文 51 篇 · 总被引 1455 次 · h-index 20

代表论文

• A Mosaic Nanoparticle Vaccine Elicits Potent Mucosal Immune Response with Significant Cross‐Protection Activity against Multiple SARS‐CoV‐2 Sublineages (2023 · Advanced Science · 被引 35)
• Nanobody-derived bispecific CAR-T cell therapy enhances the anti-tumor efficacy of T cell lymphoma treatment (2023 · Molecular Therapy — Oncolytics · 被引 35)
• The construction of modular universal chimeric antigen receptor T (MU-CAR-T) cells by covalent linkage of allogeneic T cells and various antibody fragments (2024 · Molecular Cancer · 被引 23)
• The receptor binding domain of SARS-CoV-2 Omicron subvariants targets Siglec-9 to decrease its immunogenicity by preventing macrophage phagocytosis (2024 · Nature Immunology · 被引 18)
• Development of nanobodies targeting hepatocellular carcinoma and application of nanobody-based CAR-T technology (2024 · Journal of Translational Medicine · 被引 15)
• The efficacy of acupuncture therapies in cervical spondylotic radiculopathy: A network meta-analysis (2024 · Heliyon · 被引 14)